Alnylam Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (31)

Latest Posts

About This Stock More About This Stock
Is Alnylam Pharmaceuticals Finally Ready For Takeoff?
Article By: TipRanks
Thursday, November 15, 2018 7:27 AM EST
Alnylam is the first major biotech company to focus on RNAi therapies for genetic diseases. This gives the company a leg up, as it faces little competition right now for patents or drug approval.
In this article: ALNY
Read
5 Drug/Biotech Stocks Likely To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research
Sunday, October 28, 2018 2:00 PM EST
There are a number of drug/biotech companies poised to surpass third-quarter estimates. However, given the large number of drug/biotech firms, the task of selecting stocks with possibilities to beat could appear quite daunting.
In this article: REGN, AGN, AMGN, ALNY, AMAG
Read
Alnylam: Analysts See A Star On The Rise
Article By: TipRanks
Thursday, September 6, 2018 4:37 AM EST
Biopharma company Alnylam Pharmaceuticals has built a brand on its innovative RNAi therapeutics. Alnylam landed on Forbes’ ‘100 Most Innovative Growth Companies’ list.
In this article: ALNY
Read
3 ‘Strong Buy’ Stocks You Need On Your Investing Radar
Article By: TipRanks
Tuesday, August 7, 2018 1:44 PM EST
Top analysts just can’t get enough of these three hot stocks.
In this article: ALNY, ATVI, LRCX
Read
5 Of The Best-Performing Biotech Stocks Of 2017
Article By: Arpita Dutt
Sunday, December 31, 2017 3:46 PM EST
2017 turned out to be a pretty good year for the biotech sector. The sector had been struggling due to the drug pricing controversy, mixed results, slower-than-expected new product launches, increasing competition and pipeline setbacks.
In this article: XOMA, DVAX, SGMO, ALNY, BLUE, PFE, GILD
Read

PARTNER HEADLINES

Latest Tweets for $ALNY

No tweets yet!